Skip to content
10-Q

Quarterly Report

NORTHERN GENESIS ACQUISITION CORP. III

0001213900-22-029061

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 23, 2022 21.56M sh
Shares Diluted Q1 2022 · Mar 31, 2022 21.56M sh
Shares Diluted Q1 2022 · Mar 31, 2021 4.58M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$611.11K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $95.63K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $256.74K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$10.45M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$13.12M
Current Liabilities Q1 2022 · Mar 31, 2022 $681.04K
Current Liabilities Q1 2022 · Dec 31, 2021 $432.91K
Total Liabilities Q1 2022 · Mar 31, 2022 $10.59M
Total Liabilities Q1 2022 · Dec 31, 2021 $13.46M
Current Assets Q1 2022 · Mar 31, 2022 $113.54K
Current Assets Q1 2022 · Dec 31, 2021 $330.85K
Total Assets Q1 2022 · Mar 31, 2022 $172.59M
Total Assets Q1 2022 · Dec 31, 2021 $172.79M
Eps Diluted Q1 2022 · Mar 31, 2022 $0.12
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.09
Eps Basic Q1 2022 · Mar 31, 2022 $0.12
Net Income Q1 2022 · Mar 31, 2022 $2.67M
Operating Income Q1 2022 · Mar 31, 2022 −$465.44K